Dr. Laskin wrote a new post on the GRACE site, here, describing in some detail the negative ESCAPE trial of sorafenib with chemo for first line treatment of advanced NSCLC.

  Although we’re mothballing the OncTalk site and not really adding to it, some people have noted that GRACE doesn’t yet offer a way to get alerts when new posts are written.  That feature is in the works.  In the meantime, I can write a brief note here that triggers an alert until we have the proper mechanism in place.